The polo-like kinase 1 (PLK1) inhibits type I interferon induction via interaction with Cardif

被引：0
|
作者：
Vitour, Damien
Dabo, Stephanie
Vidalain, Pierre-Olivier
Vilasco, Myriam
Pour, Malek Ahmadi
Lin, Rongtuan
Hiscott, John
Jacob, Yves
Tangy, Frederic
Meurs, Eliane F.
机构：
[1] Inst Pasteur, Hepacivirus, Paris, France
[2] Inst Pasteur, Viral Genom & Vaccinat, Paris, France
[3] Lady Davis Inst Med Res, Montreal, PQ, Canada
[4] Inst Pasteur, Papilloma Virus & Human Canc, Paris, France
来源：
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH | 2007年 / 27卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：722 / 722
页数：1
相关论文
共 50 条
  • [41] Polo-like kinase 1 (PLK1)-dependent phosphorylation of methylenetetrahydrofolate reductase (MTHFR) regulates replication via histone methylation
    Li, Xueyan
    Nai, Shanshan
    Ding, Yuehe
    Geng, Qizhi
    Zhu, Bingtao
    Yu, Kai
    Zhu, Wei-Guo
    Dong, Meng-Qiu
    Su, Xiao-Dong
    Xu, Xingzhi
    Li, Jing
    CELL CYCLE, 2017, 16 (20) : 1933 - 1942
  • [42] Inhibition of polo-like kinase 1 (Plk1) induces a senescence-like phenotype in human melanoma cells
    Cholewa, B. D.
    Desotelle, J. A.
    Ahmad, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S242 - S242
  • [43] Pooled shRNA screen for sensitizers to inhibition of the mitotic regulator polo-like kinase (PLK1)
    Liu-Sullivan, Nancy
    Zhang, Jianping
    Bakleh, Amy
    Marchica, John
    Li, Jinyu
    Siolas, Despina
    Laquerre, Sylvie
    Degenhardt, Yan Y.
    Wooster, Richard
    Chang, Kenneth
    Hannon, Gregory F.
    Powers, Scott
    ONCOTARGET, 2011, 2 (12) : 1 - 11
  • [44] The significance of immunoexpression of Polo Like Kinase 1 (PLK1) in retinoblastoma
    Kusuma, Yan Adhitya
    Fauziah, Dyah
    Rahaju, Anny Setijo
    BALI MEDICAL JOURNAL, 2023, 12 (01) : 749 - 752
  • [45] Expression of polo-like kinase (PLK1) in thin melanomas: a novel marker of metastatic disease
    Kneisel, L
    Strebhardt, K
    Bernd, A
    Wolter, M
    Binder, A
    Kaufmann, R
    JOURNAL OF CUTANEOUS PATHOLOGY, 2002, 29 (06) : 354 - 358
  • [46] Inhibitors of the polo-like protein kinase Plk-1
    Nixey, Thomas
    Boylan, John
    Hulme, C.
    Powers, David
    Smith, Adrian
    Wong, Andrew
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [47] Induction of antitumor immunity using dendritic cells electroporated with Polo-like kinase 1 (Plk1) mRNA in murine tumor models
    Park, Jung-Sun
    Sohn, Hyun-Jung
    Park, Gyeong-Sin
    Chung, Yeun-Jun
    Kim, Tai-Gyu
    CANCER SCIENCE, 2011, 102 (08) : 1448 - 1454
  • [48] Mitotic phosphotyrosine network analysis reveals that tyrosine phosphorylation regulates Polo-like kinase 1 (PLK1)
    Caron, Danielle
    Byrne, Dominic P.
    Thebault, Philippe
    Soulet, Denis
    Landry, Christian R.
    Eyers, Patrick A.
    Elowe, Sabine
    SCIENCE SIGNALING, 2016, 9 (458)
  • [49] Polo-like Kinase 1 (Plk1) as a Novel Drug Target in Chronic Myeloid Leukemia: Overriding Imatinib Resistance with the Plk1 Inhibitor BI 2536
    Gleixner, Karoline V.
    Ferenc, Veronika
    Peter, Barbara
    Gruze, Alexander
    Meyer, Renata A.
    Hadzijusufovic, Emir
    Cerny-Reiterer, Sabine
    Mayerhofer, Matthias
    Pickl, Winfried F.
    Sillaber, Christian
    Valent, Peter
    CANCER RESEARCH, 2010, 70 (04) : 1513 - 1523
  • [50] β-Hydroxyisovalerylshikonin induces apoptosis in human leukemia cells by inhibiting the activity of a polo-like kinase 1 (PLK1)
    Yutaka Masuda
    Ayano Nishida
    Kouichi Hori
    Takahiro Hirabayashi
    Sachiko Kajimoto
    Shigeo Nakajo
    Takeshi Kondo
    Masahiro Asaka
    Kazuyasu Nakaya
    Oncogene, 2003, 22 : 1012 - 1023
12345